The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Administration of sipuleucel-T (sip-T) infusions (infs) outside of the clinical trial setting: Data from the PROCEED registry.
 
Celestia S. Higano
Employment - Cell Therapeutics (I)
Leadership - Cell Therapeutics (I)
Stock and Other Ownership Interests - Cell Therapeutics (I)
Consulting or Advisory Role - AbbVie; Bayer; BHR Pharma; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Orion; Pfizer; Sanofi
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Exelixis (Inst); Genentech (Inst); Medivation (Inst); Millennium (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Astellas Pharma; Bayer; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Ockham; Orion; Pfizer; Sanofi; Teva
 
A. Oliver Sartor
Consulting or Advisory Role - Dendreon
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Janssen Biotech
Speakers' Bureau - Bayer; Caris MPI; Dendreon; GlaxoSmithKline; Medivation; Millennium; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Shaker R. Dakhil
No Relationships to Disclose
 
Raoul S. Concepcion
Consulting or Advisory Role - Cardinal Health; Chan Soon-Shiong Institute for Advanced Health; Dendreon; MDxHealth
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; GHI Pharma; Janssen
Research Funding - BN ImmunoTherapeutics; CUSP; Dendreon; Janssen; Takeda
 
Christopher Michael Pieczonka
Stock and Other Ownership Interests - Titan Medical
Consulting or Advisory Role - Bayer; Janssen; Myriad Pharmaceuticals
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst)
 
Jeffrey L. Vacirca
Consulting or Advisory Role - Dendreon
Research Funding - Dendreon
 
Ronald F. Tutrone
Stock and Other Ownership Interests - Nymox
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Dendreon; GTx; Janssen; Medivation; Nymox
Travel, Accommodations, Expenses - Bayer; Dendreon; Janssen
 
Carl A. Olsson
Leadership - American Urological Association
Stock and Other Ownership Interests - Egenix
Research Funding - Advantagene; Dendreon; Exosome Diagnostics; Medivation
Patents, Royalties, Other Intellectual Property - Part owner of patent used by Dianon
 
David F. Penson
Research Funding - Astellas Pharma (Inst); Dendreon (Inst); Medivation (Inst)
 
Craig Biggs
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Jennifer Susan LIll
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Todd E. Gray
Employment - Dendreon
 
Candice McCoy
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Matthew R. Cooperberg
Consulting or Advisory Role - Astellas Pharma; Dendreon; Myriad Genetics
Research Funding - Dendreon; GenomeDx; Genomic Health
Travel, Accommodations, Expenses - Dendreon
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation